Cerevel Therapeutics Holdings, Inc.
CEREDelisted Aug 1, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001805387
Cerevel Therapeutics Holdings, Inc. was delisted on Aug 1, 2024; its insiders filed their last Form 4 on Aug 5, 2024; 231 institutions reported holding it in 13F filings for Q2 2024, worth $6.42B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q1 2024
Institutional positions in Cerevel Therapeutics Holdings, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 210
- +16 vs. Q4 2023
- Shares held
- 157.8M
- +2.01M (+1.3%) vs. Q4 2023
- Total value
- $6.67B
- +$64.2M (+1.0%) vs. Q4 2023
- New holders
- 45
- 82 more added
- Sold out
- 29
- 49 more reduced
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CERE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $1.16K |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 2 | $20.7K |
| Q2 2024 | 231 | $6.42B |
| Q1 2024 | 210 | $6.67B |
| Q4 2023 | 195 | $6.61B |
| Q3 2023 | 119 | $3.07B |
| Q2 2023 | 125 | $4.41B |
| Q1 2023 | 119 | $3.30B |
| Q4 2022 | 125 | $4.23B |
| Q3 2022 | 115 | $3.76B |
| Q2 2022 | 109 | $3.28B |
| Q1 2022 | 107 | $4.27B |
| Q4 2021 | 107 | $3.84B |
| Q3 2021 | 94 | $3.51B |
| Q2 2021 | 82 | $2.65B |
| Q1 2021 | 62 | $1.37B |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Cerevel Therapeutics Holdings, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Paradigm Biocapital Advisors LP | 2,330,508 | $98.5M | 3.47% | 00.0% | Unchanged |
| Alpine Associates Management Inc. | 2,341,394 | $99.0M | 3.86% | +697,294+42.4% | Added |
| UBS Oconnor LLC | 3,230,529 | $136.6M | 3.93% | +1,505,529+87.3% | Added |
| FIL Ltd | 3,249,000 | $137.3M | 0.14% | +483,000+17.5% | Added |
| State Street Corp | 3,528,470 | $149.1M | 0.01% | +676,651+23.7% | Added |
| BlackRock Inc. | 5,448,620 | $230.3M | 0.01% | −578,905−9.6% | Reduced |
| Vanguard Group Inc | 7,463,911 | $315.5M | 0.01% | +88,941+1.2% | Added |
| Avoro Capital Advisors LLC | 7,555,555 | $319.4M | 3.73% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 10,794,876 | $456.3M | 8.04% | −170,317−1.6% | Reduced |
| Bain Capital Investors LLC | 65,679,781 | $2.78B | 61.94% | 00.0% | Unchanged |
| Westfield Capital Management Co LP | 0 | $0 | 0.00% | −785,494−100.0% | Sold out |
| American Century Companies Inc | 0 | $0 | 0.00% | −413,203−100.0% | Sold out |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0 | $0 | 0.00% | −377,329−100.0% | Sold out |
| Governors Lane LP | 0 | $0 | 0.00% | −364,400−100.0% | Sold out |
| Calamos Advisors LLC | 0 | $0 | 0.00% | −305,303−100.0% | Sold out |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −299,891−100.0% | Sold out |
| Avidity Partners Management LP | 0 | $0 | 0.00% | −276,888−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −253,424−100.0% | Sold out |
| Kapitalo Investimentos Ltda | 0 | $0 | 0.00% | −180,000−100.0% | Sold out |
| Candriam Luxembourg S.C.A. | 0 | $0 | 0.00% | −167,221−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −66,655−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −43,382−100.0% | Sold out |
| Wellington Management Group LLP | 0 | $0 | 0.00% | −35,578−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −13,607−100.0% | Sold out |
| Cinctive Capital Management LP | 0 | $0 | 0.00% | −10,844−100.0% | Sold out |
| Moore Capital Management, LP | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −8,215−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −8,000−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −7,699−100.0% | Sold out |
| D L Carlson Investment Group Inc | 0 | $0 | 0.00% | −7,500−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −6,600−100.0% | Sold out |
| Cipher Capital LP | 0 | $0 | 0.00% | −6,530−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −5,803−100.0% | Sold out |
| Artal Group S.A. | 0 | $0 | 0.00% | −5,041−100.0% | Sold out |
| Centaurus Financial, Inc. | 0 | $0 | 0.00% | −2,800−100.0% | Sold out |
| Cambridge Trust Co | 0 | $0 | 0.00% | −250−100.0% | Sold out |
| Itau Unibanco Holding S.A. | 0 | $0 | 0.00% | −92−100.0% | Sold out |
| Oliver Lagore Vanvalin Investment Group | 0 | $0 | 0.00% | −60−100.0% | Sold out |
| GPS Wealth Strategies Group, LLC | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| Kellner Capital, LLC | – | – | – | – | Not filed |